Literature DB >> 10398265

Neocentromere at 13q32 in one of two stable markers derived from a 13q21 break.

H Rivera1, A I Vasquez, D García-Cruz, J A Crolla.   

Abstract

A 10-month-old girl with psychomotor retardation, microcephaly, bilateral microphthalmia, and postaxial polydactyly of the feet was karyotyped using banding techniques and (single or dual color) fluorescent in situ hybridization (FISH) with four probes: D13Z1/D21Z1, pancentromeric, pantelomeric, and a mix of 13q subtelomeric and 13/21 alphoid repeats. She was found to have a 47-chromosome karyotype in which a normal 13 was replaced by two stable markers derived from a breakpoint at 13q21.1, namely a del(13)(q21.1) and an isofragment(13) (qter-->q21.1::q21.1-->qter). The latter had a single C-negative but Cd-positive primary constriction at 13q32 which, however, was not obvious in about 12% of the cells. FISH studies showed that the small 13q- had the 13-centromere and a 13q telomere (as shown for a specific 13q subtelomeric signal) onto the broken end whereas the isofragment lacked alphoid signals but had 13q subtelomeric sequences on both ends. Parental karyotypes were normal. The patient's rearrangement represents the eighth chromosome-13-derived marker with a nonalphoid neocentromere located at 13q. All in all, such neocentromeres have been described in 29 markers derived from chromosomes 2, 3, 8-11, 13-15, 20, and Y, and plausibly result from the epigenetic activation of a latent centromere, which may even be a telomere with neocentric activity. The 13q telomere found in the del(13q) was probably captured from the homologous chromosome. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398265     DOI: 10.1002/(sici)1096-8628(19990806)85:4<385::aid-ajmg15>3.0.co;2-p

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Karyotype comparison and phylogenetic relationships of Pipistrellus-like bats (Vespertilionidae; Chiroptera; Mammalia).

Authors:  M Volleth; G Bronner; M C Göpfert; K G Heller; H S Yong
Journal:  Chromosome Res       Date:  2001       Impact factor: 5.239

Review 2.  Neocentromeres: new insights into centromere structure, disease development, and karyotype evolution.

Authors:  Owen J Marshall; Anderly C Chueh; Lee H Wong; K H Andy Choo
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

Review 3.  Molecular cytogenetic analysis of eight inversion duplications of human chromosome 13q that each contain a neocentromere.

Authors:  P E Warburton; M Dolled; R Mahmood; A Alonso; S Li; K Naritomi; T Tohma; T Nagai; T Hasegawa; H Ohashi; L C Govaerts; B H Eussen; J O Van Hemel ; C Lozzio; S Schwartz; J J Dowhanick-Morrissette; N B Spinner; H Rivera; J A Crolla; C Yu; D Warburton
Journal:  Am J Hum Genet       Date:  2000-04-24       Impact factor: 11.025

Review 4.  Neocentromeres: role in human disease, evolution, and centromere study.

Authors:  David J Amor; K H Andy Choo
Journal:  Am J Hum Genet       Date:  2002-08-26       Impact factor: 11.025

5.  Neocentric X-chromosome in a girl with Turner-like syndrome.

Authors:  Morteza Hemmat; Boris T Wang; Peter E Warburton; Xiaojing Yang; Fatih Z Boyar; Mohammed El Naggar; Arturo Anguiano
Journal:  Mol Cytogenet       Date:  2012-06-09       Impact factor: 2.009

Review 6.  Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature.

Authors:  Brian P Brooks; Jeanne M Meck; Bassem R Haddad; Claude Bendavid; Delphine Blain; Jeffrey A Toretsky
Journal:  BMC Med Genet       Date:  2006-01-13       Impact factor: 2.103

7.  Case Report: Prenatal Identification of a De Novo Mosaic Neocentric Marker Resulting in 13q31.1→qter Tetrasomy in a Mildly Affected Girl.

Authors:  Avinash V Dharmadhikari; Elaine M Pereira; Carli C Andrews; Michael Macera; Nina Harkavy; Ronald Wapner; Vaidehi Jobanputra; Brynn Levy; Mythily Ganapathi; Jun Liao
Journal:  Front Genet       Date:  2022-07-19       Impact factor: 4.772

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.